Vietnam considers granting registration certificate for conditional circulation to Nano Covax
The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
Nano Covax vaccine likely to get a registration certificate for conditional circulation (Photo: Ministry of Health).
Hanoi (VNA) - The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
In its statement issued on August 28, the National Committee for Ethics in Biomedical Research affirmed that the homegrown COVID-19 vaccine meets safety requirements.
The statement also mentioned the committee’s conclusion at its urgent meeting on August 22 to evaluate the mid-term result of Nano Covax's phase 3 clinical trials until August 18, stressing that the COVID-19 vaccine has immunogenicity on the tried cases.
The committee also requested additional results of the plaque reduction neutralization test (PRNT) of Coronavirus on Delta and Alpha variants to meet enough test results in accordance with the approved plan.
The committee proposed domestic vaccine developer Nanogen Pharmaceutical Biotechnology JSC and the research team to complete a report on updating and supplementing the clinical trial research results of Nano Covax and send it to the ethics committee and the advisory council for evaluation and approval.
“If Nano Covax vaccine is granted a registration certificate for circulation, it can only be used conditionally basing on the quantity and plan approved by the Ministry of Health," the statement said.
People administered with the vaccine must be closely monitored for safety similar to those joined the phase 3b clinical trials, it added.
The two agencies will specify conditions for continuing or stopping circulation when they collect enough data on the protective efficacy and safety of the vaccine, according to the statement.
According to the ethics committee, the MoH has created favorable conditions for domestic vaccine producers, including Nanogen, to research and develop COVID-19 vaccines.
🐈 Previously, the ethics committee convened to accept the result reports of clinical trials of the phases 3a, and assess the results of the phase 3b, of safety and immunogenicity of the vaccine developed by Nanogen.
Nano Covax, a recombinant spike protein vaccine, is the forerunner in the race for domestically produced COVID-19 vaccine, followed by COVIVAC from the Institute of Vaccines and Biologic Medical and mRNA vaccine ARCT-154 (by Arcturus and VinBioCare) just starting phase 2 trials./.
Research centres on July 27 began the injection of the second shots of COVID-19 Nano Covax vaccine for 12,000 volunteers as part of the third-phase human trials of the home-grown vaccine, according to the Military Medical University under the Ministry of National Defence.
The Ministry of Health in collaboration with the World Health Organisation organized a webinar on August 4 to consult experts on the evaluation of clinical research data and approval of vaccines against COVID-19 in emergency situations.
The National Ethics Committee in Biomedical Research under the Ministry of Health on August 7 held an urgent online meeting to review the results of the first phase of clinical trials of Vietnam’s domestically developed COVID-19 vaccine, Nano Covax, and to pass the mid-term assessment of its second phase.
Vietnam may be able to produce a COVID-19 vaccine in September if everything goes smoothly, Prime Minister Pham Minh Chinh told scientists, units and businesses participating in vaccine production and research at a meeting on August 12.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Nano Covax vaccine likely to get a registration certificate for conditional circulation (Photo: Ministry of Health). 
